@Salat
In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of ?3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.)
G. Zhao a, b, X.-W. Zheng a, G.-W. Qin c, Y. Gai a, Z.-H. Jiang a and L.-H. Guo
Journal Cellular and Molecular Life Sciences
ISSN 1420-682X (Print) 1420-9071 (Online)
Issue Volume 66, Number 9 / May, 2009 Pages 1617-1629
DOI 10.1007/s00018-009-9030-9
Abstract
Cocktail recipes containing Psoralea corylifolia seeds (PCS) are used to empirically treat Parkinson disease. A PCS isolate ?3,2-hydroxybakuchiol (BU) can inhibit dopamine uptake in dopamine transporter (DAT) transfected Chinese hamster ovary (CHO) cells, and dopamine reuptake blockade may provide an alternative approach for ameliorating parkinsonism. Here, we assessed the potential dopaminergic neuroprotective, and antiparkinsonian-like activity of BU. BU sample size was increased by using a scale-up extraction paradigm. Pharmacologically, BU significantly protected SK-N-SH cells from 1-methyl-4-phenylpyridinium (MPP+) insult, produced striking inhibitory actions on dopamine/norepinephrine uptake and WIN35,428 binding in synaptosomes on in vivo administration, and significantly preventing poor performance on rotarod and dopaminergic loss in substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice. BU acts by protecting dopaminergic neurons from MPP+ injury and preventing against MPTP-induced behavioral and histological lesions in the Parkinson’s disease (PD) model, possibly by inhibiting monoamine transporters. These findings suggest that BU could be meaningful in PD treatment.
Keywords. ?3,2-hydroxybakuchiol - scale-up extraction - dopamine transporter - reuptake inhibitor - Parkinson’s disease
Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions
Gang Zhaoa, b, Shao-Yun Zanga, Xiang-Wei Zhengb, Xiao-Hua Zhangb and Li-He Guoa
Biochemical Pharmacology
Volume 75, Issue 9, 1 May 2008, Pages 1835-1847
DOI:10.1016/j.bcp.2008.01.014
Abstract
Monoamine transporters play key roles in controlling monoamine levels and modulating monoamine reuptake. The objective of the present study was to identify monoamine transporter inhibitors from herbal sources. We discovered that bakuchiol analogs isolated from Fructus Psoraleae inhibited monoamine transporter uptake to differing degrees. The bakuchiol analog, ?3,2-hydroxybakuchiol was the most potent and efficacious reuptake blocker and was thus selected as the candidate target. Monoamine transporter inhibition by ?3,2-hydroxybakuchiol was more selective for the dopamine transporter (DAT) (IC50 = 0.58 ± 0.1 ?M) and norepinephrine transporter (NET) (IC50 = 0.69 ± 0.12 ?M) than for the serotonin transporter (SERT) (IC50 = 312.02 ± 56.69 ?M). ?3,2-Hydroxybakuchiol exhibited greater potency (pEC50 for DAT and NET) than bupropion and exhibited similar efficacy (Emax for DAT and/or NET) to bupropion and GBR12,935. Pharmacokinetically, ?3,2-hydroxybakuchiol competitively inhibited DAT and NET with partial reversibility and occupied cocaine binding sites. Moreover, ?3,2-hydroxybakuchiol counteracted 1-methyl-4-phenylpyridinium-induced toxicity in cells expressing DAT with similar efficacy to GBR12,935. In vivo studies showed that ?3,2-hydroxybakuchiol increased the activity of intact mice and improved the decreased activity of reserpinized mice. In the conditioned place preference test, preference scores in intact mice were unaffected by ?3,2-hydroxybakuchiol treatment. Bakuchiol analogs, especially ?3,2-hydroxybakuchiol, are monoamine transporter inhibitors involved in regulating dopaminergic and noradrenergic neurotransmission and may have represented potential pharmacotherapies for disorders such as Parkinson's disease, depression, and cocaine addiction.
Keywords: Bakuchiol analogs; Monoamine transporter; Dopamine transporter; Norepinephrine transporter; Reuptake inhibitor